{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 58,
        "end": 87
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 90,
        "end": 93
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 108,
        "end": 137
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 140,
        "end": 143
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 220,
        "end": 247
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 260,
        "end": 265
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 220,
        "end": 228
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23617284_5",
  "text": "Our previous studies have demonstrated the involvement of xeroderma pigmentosum group A ( XPA ) codon23 and xeroderma pigmentosum group D ( XPD ) codon751 single-nucleotide polymorphisms ( SNPs ) in clinical response to platinum based chemotherapy in advanced NSCLC patients ."
}
